MA27076A1 - Regime de dosage et composition pharmaceutique pour contraception d'urgence - Google Patents

Regime de dosage et composition pharmaceutique pour contraception d'urgence

Info

Publication number: MA27076A1
Authority: MA; Morocco
Prior art keywords: pharmaceutical composition; dosage regime; emergency contraception; contraception; emergency
Prior art date: 2001-11-27

Application number

MA27643A

Other languages

English (en)

Inventor

Look Paul F A Van

Illesne Balogh

Katalin Komandi

Laszlo Nemes

Zsolt Szabo

Original Assignee

Richter Gedeon Vegyeszet

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-11-27

Filing date

2004-04-21

Publication date

2004-12-20

2004-04-21 Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet

2004-12-20 Publication of MA27076A1 publication Critical patent/MA27076A1/fr

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Endocrinology (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Diabetes (AREA)
Reproductive Health (AREA)
Gynecology & Obstetrics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Steroid Compounds (AREA)

MA27643A 2001-11-27 2004-04-21 Regime de dosage et composition pharmaceutique pour contraception d'urgence MA27076A1 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
HU0105173A HU227198B1 (en)	2001-11-27	2001-11-27	Pharmaceutical composition for emergency contraception containing levonorgestrel

Publications (1)

Publication Number	Publication Date
MA27076A1 true MA27076A1 (fr)	2004-12-20

Family

ID=89998939

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MA27643A MA27076A1 (fr)	2001-11-27	2004-04-21	Regime de dosage et composition pharmaceutique pour contraception d'urgence

Country Status (33)

Country	Link
US (1)	US20050288264A2 (fr)
EP (1)	EP1448207B1 (fr)
JP (1)	JP2005516904A (fr)
KR (1)	KR100908161B1 (fr)
CN (1)	CN1551774A (fr)
AP (1)	AP1849A (fr)
AT (1)	ATE293978T1 (fr)
AU (1)	AU2002347401A1 (fr)
BR (1)	BR0210595A (fr)
CA (1)	CA2450359C (fr)
DE (1)	DE60203929T2 (fr)
DK (1)	DK1448207T3 (fr)
EA (1)	EA006545B1 (fr)
EC (1)	ECSP045171A (fr)
ES (1)	ES2239727T3 (fr)
GE (1)	GEP20063882B (fr)
HR (1)	HRP20040584B1 (fr)
HU (1)	HU227198B1 (fr)
IL (1)	IL159394A0 (fr)
IS (1)	IS2691B (fr)
MA (1)	MA27076A1 (fr)
MX (1)	MXPA04005104A (fr)
NO (1)	NO333984B1 (fr)
NZ (1)	NZ530056A (fr)
OA (1)	OA12730A (fr)
PL (1)	PL206010B1 (fr)
PT (1)	PT1448207E (fr)
RS (1)	RS50768B (fr)
SI (1)	SI1448207T1 (fr)
TN (1)	TNSN04048A1 (fr)
UA (1)	UA79942C2 (fr)
WO (1)	WO2003045397A1 (fr)
ZA (1)	ZA200404114B (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2674776A1 (fr) *	2006-12-20	2008-07-03	Duramed Pharmaceuticals, Inc.	Formes posologiques solides se desintegrant oralement comprenant de la progestine et leurs procedes de fabrication et d'utilisation
EA201070715A1 (ru) *	2007-12-20	2011-02-28	Тева Вимен'С Хелс, Инк.	Режимы дозирования, фармацевтические композиции и упаковки для экстренной контрацепции
US8512745B2 (en)	2008-12-08	2013-08-20	Laboratoire Hra Pharma	Ulipristal acetate tablets
EP2365811A1 (fr) *	2008-12-12	2011-09-21	Laboratoire HRA Pharma	Méthode de contraception
HRP20161437T1 (hr)	2009-04-14	2017-02-10	Laboratoire Hra Pharma	Postupak hitne kontracepcije
NZ597239A (en) *	2009-06-23	2013-07-26	Bayer Pharma AG	Pharmaceutical composition for emergency contraception
CN101732324B (zh) *	2009-12-31	2011-12-07	广州朗圣药业有限公司	一种含有左炔诺孕酮的紧急避孕药物组合物及其制备方法
AU2012264601C1 (en)	2011-06-01	2018-01-25	Estetra Srl	Process for the production of estetrol intermediates
PT2714710T (pt)	2011-06-01	2016-07-12	Estetra Sprl	Processo para a produção de intermediários de estetrol
EP2383279A1 (fr)	2011-07-19	2011-11-02	Pantarhei Bioscience B.V.	Procédé de préparation d'estetrol
HRP20170797T1 (hr) *	2011-08-11	2017-08-11	Estetra S.P.R.L.	Primjena estetrola kao hitnog kontraceptiva
WO2014079840A1 (fr)	2012-11-22	2014-05-30	Bayer Pharma Aktiengesellschaft	Utilisation et schémas posologiques d'application d'une composition pharmaceutique contenant du lévonorgestrel et un inhibiteur de cox pour la contraception à la demande
TN2015000511A1 (en)	2013-05-23	2017-04-06	Bayer Pharma AG	Pharmaceutical composition and the use thereof, and application regime of said pharmaceutical composition for on-demand contraception
CN103877058A (zh) *	2014-03-26	2014-06-25	邵娜	一种左炔诺孕酮片及其制备工艺
MY195019A (en)	2015-06-18	2023-01-03	Estetra Sprl	Orodispersible dosage unit containing an estetrol component
JP6866560B2 (ja)	2015-06-18	2021-04-28	エステトラソシエテプリーヴアレスポンサビリテリミテ	エステトロール成分を含有する口腔内崩壊性投与単位
MD3310346T2 (ro)	2015-06-18	2021-06-30	Estetra Sprl	Comprimată orodispersabilă ce conține estetrol
HUE054589T2 (hu)	2015-06-18	2021-09-28	Estetra Sprl	Szájban diszpergálódó esztetrol tartalmú tabletta
KR102712911B1 (ko)	2016-08-05	2024-10-04	에스테트라, 소시에떼 아 레스폰서빌리떼 리미떼	월경통 및 생리통의 관리방법
TWI801561B (zh)	2018-04-19	2023-05-11	比利時商依思特拉私人有限責任公司	化合物及其用於緩解絕經相關症狀的用途
JOP20200260A1 (ar)	2018-04-19	2019-10-19	Estetra Sprl	مركبات واستخداماتها للتخفيف من الأعراض المصاحبة لانقطاع الطمث
CN110917154A (zh) *	2019-12-12	2020-03-27	上海信谊天平药业有限公司	一种左炔诺孕酮片的制备方法
TWI893101B (zh)	2020-04-16	2025-08-11	比利時商埃斯特拉有限責任公司	具有降低之副作用之避孕組成物
WO2022026901A2 (fr) *	2020-07-30	2022-02-03	Acer Therapeutics Inc.	Antagonistes nk pour la contraception
CN119523923A (zh) *	2024-11-21	2025-02-28	华中药业股份有限公司	一种左炔诺孕酮片及其制备方法

2001
- 2001-11-27 HU HU0105173A patent/HU227198B1/hu unknown
2002
- 2002-11-26 DK DK02783334T patent/DK1448207T3/da active
- 2002-11-26 UA UA20040504015A patent/UA79942C2/uk unknown
- 2002-11-26 OA OA1200400148A patent/OA12730A/fr unknown
- 2002-11-26 CA CA2450359A patent/CA2450359C/fr not_active Expired - Lifetime
- 2002-11-26 KR KR1020047002069A patent/KR100908161B1/ko not_active Expired - Lifetime
- 2002-11-26 ES ES02783334T patent/ES2239727T3/es not_active Expired - Lifetime
- 2002-11-26 PT PT02783334T patent/PT1448207E/pt unknown
- 2002-11-26 DE DE60203929T patent/DE60203929T2/de not_active Expired - Lifetime
- 2002-11-26 PL PL369520A patent/PL206010B1/pl unknown
- 2002-11-26 SI SI200230132T patent/SI1448207T1/xx unknown
- 2002-11-26 AU AU2002347401A patent/AU2002347401A1/en not_active Abandoned
- 2002-11-26 CN CNA028137523A patent/CN1551774A/zh active Pending
- 2002-11-26 MX MXPA04005104A patent/MXPA04005104A/es active IP Right Grant
- 2002-11-26 AP APAP/P/2004/003046A patent/AP1849A/en active
- 2002-11-26 EA EA200400731A patent/EA006545B1/ru unknown
- 2002-11-26 EP EP02783334A patent/EP1448207B1/fr not_active Expired - Lifetime
- 2002-11-26 JP JP2003546899A patent/JP2005516904A/ja not_active Withdrawn
- 2002-11-26 GE GE5567A patent/GEP20063882B/en unknown
- 2002-11-26 AT AT02783334T patent/ATE293978T1/de active
- 2002-11-26 NZ NZ530056A patent/NZ530056A/en not_active IP Right Cessation
- 2002-11-26 WO PCT/HU2002/000129 patent/WO2003045397A1/fr not_active Ceased
- 2002-11-26 BR BR0210595-0A patent/BR0210595A/pt not_active Application Discontinuation
- 2002-11-26 IL IL15939402A patent/IL159394A0/xx unknown
- 2002-11-26 RS YUP-42/04A patent/RS50768B/sr unknown
- 2002-11-26 HR HR20040584 patent/HRP20040584B1/xx not_active IP Right Cessation
2003
- 2003-12-05 IS IS7065A patent/IS2691B/is unknown
2004
- 2004-03-26 TN TNP2004000048A patent/TNSN04048A1/en unknown
- 2004-04-20 NO NO20041607A patent/NO333984B1/no not_active IP Right Cessation
- 2004-04-21 MA MA27643A patent/MA27076A1/fr unknown
- 2004-05-26 ZA ZA2004/04114A patent/ZA200404114B/en unknown
- 2004-06-25 EC EC2004005171A patent/ECSP045171A/es unknown
- 2004-10-05 US US10/495,923 patent/US20050288264A2/en not_active Abandoned

Also Published As

Publication number	Publication date
IS2691B (is)	2010-10-15
PL369520A1 (en)	2005-04-18
CA2450359C (fr)	2011-05-10
US20050288264A2 (en)	2005-12-29
ATE293978T1 (de)	2005-05-15
GEP20063882B (en)	2006-07-25
RS4204A (sr)	2007-02-05
PT1448207E (pt)	2005-08-31
AP2004003046A0 (en)	2004-06-30
CN1551774A (zh)	2004-12-01
RS50768B (sr)	2010-08-31
MXPA04005104A (es)	2004-08-19
IL159394A0 (en)	2004-06-01
IS7065A (is)	2003-12-05
HU227198B1 (en)	2010-10-28
JP2005516904A (ja)	2005-06-09
HUP0105173D0 (en)	2002-02-28
SI1448207T1 (en)	2005-10-31
PL206010B1 (pl)	2010-06-30
AU2002347401A1 (en)	2003-06-10
HRP20040584A2 (en)	2005-02-28
DE60203929D1 (de)	2005-06-02
TNSN04048A1 (en)	2006-06-01
HUP0105173A2 (hu)	2003-08-28
KR20040066088A (ko)	2004-07-23
BR0210595A (pt)	2004-06-08
ECSP045171A (es)	2004-08-27
EA200400731A1 (ru)	2004-12-30
DE60203929T2 (de)	2006-01-19
NZ530056A (en)	2005-02-25
US20050032755A1 (en)	2005-02-10
KR100908161B1 (ko)	2009-07-16
ZA200404114B (en)	2005-10-26
NO333984B1 (no)	2013-11-04
UA79942C2 (en)	2007-08-10
EA006545B1 (ru)	2006-02-24
WO2003045397A1 (fr)	2003-06-05
EP1448207B1 (fr)	2005-04-27
DK1448207T3 (da)	2005-06-27
ES2239727T3 (es)	2005-10-01
HUP0105173A3 (en)	2004-03-29
CA2450359A1 (fr)	2003-06-05
OA12730A (fr)	2006-06-28
AP1849A (en)	2008-05-23
HRP20040584B1 (en)	2012-11-30
EP1448207A1 (fr)	2004-08-25
NO20041607L (no)	2004-04-20

Publication	Publication Date	Title
MA27076A1 (fr)	2004-12-20	Regime de dosage et composition pharmaceutique pour contraception d'urgence
DZ2494A1 (fr)	2003-01-25	Composition pharmaceutique d'oméprazole.
MA27026A1 (fr)	2004-12-20	Composition pharmaceutique liquide
CY2009015I1 (el)	2014-02-12	Φαρμακευτικος συνδυασμος αιθινυλεστραδιολης και δροπιρενονης για χρηση ως αντισυλληπτικο
HUS1400025I1 (hu)	2016-08-29	Feniletanolamin-származékok és az ezeket tartalmazó gyógyszerek
MA27018A1 (fr)	2004-12-20	Forme dosifiee pharmaceutique de mesylate de nelfinavir amorphe.
FR2732223B1 (fr)	1997-06-13	Composition pharmaceutique pour administration transdermique
HUP0401656A3 (en)	2012-05-02	Mch antagonists for the treatment of obesity and pharmaceutical compositions containing them
MXPA02003596A (es)	2003-10-14	Composiciones farmaceuticas novedosas de farmacos anti tubercular y procedimiento para su preparacion.
HUP0401537A3 (en)	2005-06-28	Thiohydantoins, process for their preparation, pharmaceutical compositions containing them and use thereof for preparation of pharmaceutical compositions
HUP0203588A3 (en)	2005-01-28	Analgesic pharmaceutical compositions and their use
FR2834890B1 (fr)	2004-02-27	Composition pharmaceutique orodispersible d'agomelatine
EP1602366A4 (fr)	2013-01-09	Timbre transdermique pour l'administration de medicaments ioniques
HUP0400386A3 (en)	2006-02-28	Tablet comprising cetirizine and pseudoephedrine and its use for preparation of pharmaceutical compositions
FR2817750B1 (fr)	2003-02-21	Composition pharmaceutique de dronedarone pour administration parenterale
FR2834896B1 (fr)	2004-02-27	Composition pharmaceutique orodispersible d'ivabradine
EP1501352A4 (fr)	2007-03-07	Methodes et compositions de liberation controlee de medicaments
HUP0401862A3 (en)	2009-03-30	Novel heterocyclic compound and medicinal use thereof and pharmaceutical compositions containing them
EE05317B1 (et)	2010-08-16	Etinlstradiooli ja drospirenooni sisaldav farmatseutiline kompositsioon kasutamiseks rasestumisvastase vahendina
EP1537875A4 (fr)	2008-04-23	Medicament preventif/curatif pour l'arteriosclerose
EP1459754A4 (fr)	2005-08-31	Medicaments pour la prevention et le traitement du cancer
HUP9903375A3 (en)	2000-04-28	Synergistic pharmaceutical compositions containing olanzapine and analgetic drugs
ITMI20011284A0 (it)	2001-06-19	Composizione farmaceutica per il trattamento dell'iperfosfatemia
FR2827516B1 (fr)	2003-09-19	Composition pharmaceutique pour l'administration par voie nasale d'estradiol et de norethisterone
FR2857594B1 (fr)	2005-09-16	Composition pharmaceutique pour l'administration par voie nasale de piribedil